nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT2B7—urinary bladder cancer	0.456	1	CbGaD
Simvastatin—UGT2B7—Epirubicin—urinary bladder cancer	0.0412	0.12	CbGbCtD
Simvastatin—CYP2B6—Thiotepa—urinary bladder cancer	0.0396	0.116	CbGbCtD
Simvastatin—UGT1A1—Etoposide—urinary bladder cancer	0.0278	0.081	CbGbCtD
Simvastatin—ABCB1—Mitomycin—urinary bladder cancer	0.0268	0.0781	CbGbCtD
Simvastatin—ABCC2—Carboplatin—urinary bladder cancer	0.0201	0.0587	CbGbCtD
Simvastatin—ABCC2—Cisplatin—urinary bladder cancer	0.0172	0.0501	CbGbCtD
Simvastatin—ABCC2—Etoposide—urinary bladder cancer	0.0169	0.0493	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—urinary bladder cancer	0.0135	0.0393	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—urinary bladder cancer	0.0127	0.037	CbGbCtD
Simvastatin—CYP3A4—Thiotepa—urinary bladder cancer	0.0122	0.0355	CbGbCtD
Simvastatin—ABCC2—Doxorubicin—urinary bladder cancer	0.0115	0.0336	CbGbCtD
Simvastatin—ABCC2—Methotrexate—urinary bladder cancer	0.0112	0.0325	CbGbCtD
Simvastatin—CYP2B6—Cisplatin—urinary bladder cancer	0.0109	0.0319	CbGbCtD
Simvastatin—CYP2C8—Fluorouracil—urinary bladder cancer	0.00974	0.0284	CbGbCtD
Simvastatin—CYP3A5—Etoposide—urinary bladder cancer	0.00846	0.0247	CbGbCtD
Simvastatin—CYP2C8—Etoposide—urinary bladder cancer	0.00813	0.0237	CbGbCtD
Simvastatin—ABCB1—Gemcitabine—urinary bladder cancer	0.00771	0.0225	CbGbCtD
Simvastatin—CYP2B6—Doxorubicin—urinary bladder cancer	0.00732	0.0214	CbGbCtD
Simvastatin—CYP2C9—Fluorouracil—urinary bladder cancer	0.0068	0.0198	CbGbCtD
Simvastatin—CYP2C9—Cisplatin—urinary bladder cancer	0.00577	0.0168	CbGbCtD
Simvastatin—ABCB1—Cisplatin—urinary bladder cancer	0.0056	0.0163	CbGbCtD
Simvastatin—ABCB1—Etoposide—urinary bladder cancer	0.0055	0.0161	CbGbCtD
Simvastatin—ABCB1—Doxorubicin—urinary bladder cancer	0.00375	0.011	CbGbCtD
Simvastatin—ABCB1—Methotrexate—urinary bladder cancer	0.00364	0.0106	CbGbCtD
Simvastatin—CYP2D6—Doxorubicin—urinary bladder cancer	0.00354	0.0103	CbGbCtD
Simvastatin—UGT1A1—urine—urinary bladder cancer	0.00345	0.0862	CbGeAlD
Simvastatin—CYP3A4—Etoposide—urinary bladder cancer	0.0033	0.00962	CbGbCtD
Simvastatin—Lovastatin—UGT2B7—urinary bladder cancer	0.00304	1	CrCbGaD
Simvastatin—ITGB2—prostate gland—urinary bladder cancer	0.00301	0.0753	CbGeAlD
Simvastatin—CYP3A4—Doxorubicin—urinary bladder cancer	0.00225	0.00656	CbGbCtD
Simvastatin—ITGB2—epithelium—urinary bladder cancer	0.00221	0.0553	CbGeAlD
Simvastatin—CYP2C19—urine—urinary bladder cancer	0.00187	0.0467	CbGeAlD
Simvastatin—ITGB2—female reproductive system—urinary bladder cancer	0.00164	0.0411	CbGeAlD
Simvastatin—ITGB2—vagina—urinary bladder cancer	0.00149	0.0372	CbGeAlD
Simvastatin—UGT2B7—prostate gland—urinary bladder cancer	0.00146	0.0364	CbGeAlD
Simvastatin—CYP2C9—urine—urinary bladder cancer	0.00145	0.0362	CbGeAlD
Simvastatin—UGT1A1—prostate gland—urinary bladder cancer	0.00124	0.0309	CbGeAlD
Simvastatin—CYP3A4—urine—urinary bladder cancer	0.00111	0.0276	CbGeAlD
Simvastatin—CYP2D6—urine—urinary bladder cancer	0.00109	0.0272	CbGeAlD
Simvastatin—HMGCR—prostate gland—urinary bladder cancer	0.00108	0.0269	CbGeAlD
Simvastatin—UGT2B7—renal system—urinary bladder cancer	0.000993	0.0248	CbGeAlD
Simvastatin—ITGB2—lymph node—urinary bladder cancer	0.000962	0.024	CbGeAlD
Simvastatin—HMGCR—seminal vesicle—urinary bladder cancer	0.00091	0.0227	CbGeAlD
Simvastatin—UGT1A1—renal system—urinary bladder cancer	0.000844	0.0211	CbGeAlD
Simvastatin—UGT2B7—female reproductive system—urinary bladder cancer	0.000795	0.0199	CbGeAlD
Simvastatin—HMGCR—epithelium—urinary bladder cancer	0.00079	0.0198	CbGeAlD
Simvastatin—ABCC2—prostate gland—urinary bladder cancer	0.000781	0.0195	CbGeAlD
Simvastatin—HMGCR—smooth muscle tissue—urinary bladder cancer	0.000762	0.019	CbGeAlD
Simvastatin—HMGCR—renal system—urinary bladder cancer	0.000733	0.0183	CbGeAlD
Simvastatin—HMGCR—urethra—urinary bladder cancer	0.00072	0.018	CbGeAlD
Simvastatin—SLCO1B1—renal system—urinary bladder cancer	0.000702	0.0176	CbGeAlD
Simvastatin—HMGCR—female reproductive system—urinary bladder cancer	0.000587	0.0147	CbGeAlD
Simvastatin—SLCO1A2—renal system—urinary bladder cancer	0.000572	0.0143	CbGeAlD
Simvastatin—SLCO1B1—female reproductive system—urinary bladder cancer	0.000562	0.0141	CbGeAlD
Simvastatin—ABCC2—renal system—urinary bladder cancer	0.000532	0.0133	CbGeAlD
Simvastatin—HMGCR—vagina—urinary bladder cancer	0.000531	0.0133	CbGeAlD
Simvastatin—CYP3A5—prostate gland—urinary bladder cancer	0.000529	0.0132	CbGeAlD
Simvastatin—ABCC2—female reproductive system—urinary bladder cancer	0.000426	0.0107	CbGeAlD
Simvastatin—CYP2C8—renal system—urinary bladder cancer	0.000399	0.00998	CbGeAlD
Simvastatin—CYP3A5—renal system—urinary bladder cancer	0.00036	0.00901	CbGeAlD
Simvastatin—CYP2B6—renal system—urinary bladder cancer	0.000358	0.00895	CbGeAlD
Simvastatin—HMGCR—lymph node—urinary bladder cancer	0.000343	0.00858	CbGeAlD
Simvastatin—CYP2C19—vagina—urinary bladder cancer	0.000331	0.00828	CbGeAlD
Simvastatin—CYP2C8—female reproductive system—urinary bladder cancer	0.00032	0.00799	CbGeAlD
Simvastatin—CYP2C8—vagina—urinary bladder cancer	0.000289	0.00723	CbGeAlD
Simvastatin—CYP2B6—female reproductive system—urinary bladder cancer	0.000287	0.00717	CbGeAlD
Simvastatin—CYP2C9—female reproductive system—urinary bladder cancer	0.000284	0.0071	CbGeAlD
Simvastatin—ABCB1—prostate gland—urinary bladder cancer	0.000281	0.00702	CbGeAlD
Simvastatin—CYP3A4—renal system—urinary bladder cancer	0.00027	0.00676	CbGeAlD
Simvastatin—CYP2D6—renal system—urinary bladder cancer	0.000266	0.00665	CbGeAlD
Simvastatin—CYP3A5—vagina—urinary bladder cancer	0.000261	0.00652	CbGeAlD
Simvastatin—CYP2B6—vagina—urinary bladder cancer	0.000259	0.00648	CbGeAlD
Simvastatin—ABCC2—lymph node—urinary bladder cancer	0.000249	0.00623	CbGeAlD
Simvastatin—ABCB1—seminal vesicle—urinary bladder cancer	0.000238	0.00594	CbGeAlD
Simvastatin—CYP3A4—female reproductive system—urinary bladder cancer	0.000217	0.00541	CbGeAlD
Simvastatin—CYP2D6—female reproductive system—urinary bladder cancer	0.000213	0.00533	CbGeAlD
Simvastatin—ABCB1—epithelium—urinary bladder cancer	0.000206	0.00516	CbGeAlD
Simvastatin—ABCB1—renal system—urinary bladder cancer	0.000191	0.00478	CbGeAlD
Simvastatin—ABCB1—urethra—urinary bladder cancer	0.000188	0.0047	CbGeAlD
Simvastatin—ABCB1—female reproductive system—urinary bladder cancer	0.000153	0.00383	CbGeAlD
Simvastatin—ABCB1—vagina—urinary bladder cancer	0.000139	0.00347	CbGeAlD
Simvastatin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000107	0.00142	CcSEcCtD
Simvastatin—Asthenia—Thiotepa—urinary bladder cancer	0.000107	0.00142	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000107	0.00141	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000107	0.00141	CcSEcCtD
Simvastatin—Infection—Etoposide—urinary bladder cancer	0.000107	0.00141	CcSEcCtD
Simvastatin—Pruritus—Thiotepa—urinary bladder cancer	0.000106	0.0014	CcSEcCtD
Simvastatin—Pain—Fluorouracil—urinary bladder cancer	0.000106	0.0014	CcSEcCtD
Simvastatin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000105	0.00139	CcSEcCtD
Simvastatin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000105	0.00139	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000105	0.00139	CcSEcCtD
Simvastatin—Eosinophilia—Epirubicin—urinary bladder cancer	0.000105	0.00139	CcSEcCtD
Simvastatin—Dyspnoea—Cisplatin—urinary bladder cancer	0.000105	0.00138	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000104	0.00138	CcSEcCtD
Simvastatin—Pancreatitis—Epirubicin—urinary bladder cancer	0.000104	0.00137	CcSEcCtD
Simvastatin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000104	0.00137	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000103	0.00137	CcSEcCtD
Simvastatin—Anorexia—Etoposide—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Bronchitis—Epirubicin—urinary bladder cancer	0.000102	0.00135	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000101	0.00134	CcSEcCtD
Simvastatin—Depression—Methotrexate—urinary bladder cancer	0.000101	0.00133	CcSEcCtD
Simvastatin—Gastritis—Doxorubicin—urinary bladder cancer	0.0001	0.00133	CcSEcCtD
Simvastatin—Pain—Cisplatin—urinary bladder cancer	0.0001	0.00133	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.0001	0.00132	CcSEcCtD
Simvastatin—Muscular weakness—Doxorubicin—urinary bladder cancer	0.0001	0.00132	CcSEcCtD
Simvastatin—Body temperature increased—Gemcitabine—urinary bladder cancer	9.95e-05	0.00132	CcSEcCtD
Simvastatin—Dizziness—Thiotepa—urinary bladder cancer	9.89e-05	0.00131	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	9.84e-05	0.0013	CcSEcCtD
Simvastatin—Urticaria—Fluorouracil—urinary bladder cancer	9.83e-05	0.0013	CcSEcCtD
Simvastatin—Body temperature increased—Fluorouracil—urinary bladder cancer	9.78e-05	0.00129	CcSEcCtD
Simvastatin—Eosinophilia—Doxorubicin—urinary bladder cancer	9.7e-05	0.00128	CcSEcCtD
Simvastatin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	9.67e-05	0.00128	CcSEcCtD
Simvastatin—Feeling abnormal—Cisplatin—urinary bladder cancer	9.66e-05	0.00128	CcSEcCtD
Simvastatin—Paraesthesia—Etoposide—urinary bladder cancer	9.65e-05	0.00128	CcSEcCtD
Simvastatin—Pancreatitis—Doxorubicin—urinary bladder cancer	9.61e-05	0.00127	CcSEcCtD
Simvastatin—Dyspnoea—Etoposide—urinary bladder cancer	9.58e-05	0.00127	CcSEcCtD
Simvastatin—Vomiting—Thiotepa—urinary bladder cancer	9.51e-05	0.00126	CcSEcCtD
Simvastatin—Rash—Thiotepa—urinary bladder cancer	9.43e-05	0.00125	CcSEcCtD
Simvastatin—Bronchitis—Doxorubicin—urinary bladder cancer	9.42e-05	0.00125	CcSEcCtD
Simvastatin—Dermatitis—Thiotepa—urinary bladder cancer	9.42e-05	0.00125	CcSEcCtD
Simvastatin—Headache—Thiotepa—urinary bladder cancer	9.37e-05	0.00124	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	9.36e-05	0.00124	CcSEcCtD
Simvastatin—Decreased appetite—Etoposide—urinary bladder cancer	9.34e-05	0.00124	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	9.27e-05	0.00123	CcSEcCtD
Simvastatin—Body temperature increased—Cisplatin—urinary bladder cancer	9.27e-05	0.00123	CcSEcCtD
Simvastatin—Fatigue—Etoposide—urinary bladder cancer	9.26e-05	0.00122	CcSEcCtD
Simvastatin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	9.25e-05	0.00122	CcSEcCtD
Simvastatin—Jaundice—Epirubicin—urinary bladder cancer	9.2e-05	0.00122	CcSEcCtD
Simvastatin—Pain—Etoposide—urinary bladder cancer	9.19e-05	0.00121	CcSEcCtD
Simvastatin—Constipation—Etoposide—urinary bladder cancer	9.19e-05	0.00121	CcSEcCtD
Simvastatin—Hypersensitivity—Fluorouracil—urinary bladder cancer	9.11e-05	0.00121	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	9.11e-05	0.0012	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—urinary bladder cancer	9.06e-05	0.0012	CcSEcCtD
Simvastatin—Asthenia—Gemcitabine—urinary bladder cancer	9.03e-05	0.00119	CcSEcCtD
Simvastatin—ABCB1—lymph node—urinary bladder cancer	8.97e-05	0.00224	CbGeAlD
Simvastatin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	8.94e-05	0.00118	CcSEcCtD
Simvastatin—Pruritus—Gemcitabine—urinary bladder cancer	8.9e-05	0.00118	CcSEcCtD
Simvastatin—Nausea—Thiotepa—urinary bladder cancer	8.88e-05	0.00117	CcSEcCtD
Simvastatin—Sinusitis—Epirubicin—urinary bladder cancer	8.86e-05	0.00117	CcSEcCtD
Simvastatin—Feeling abnormal—Etoposide—urinary bladder cancer	8.85e-05	0.00117	CcSEcCtD
Simvastatin—Gastrointestinal pain—Etoposide—urinary bladder cancer	8.78e-05	0.00116	CcSEcCtD
Simvastatin—Pruritus—Fluorouracil—urinary bladder cancer	8.75e-05	0.00116	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	8.66e-05	0.00115	CcSEcCtD
Simvastatin—Hypersensitivity—Cisplatin—urinary bladder cancer	8.64e-05	0.00114	CcSEcCtD
Simvastatin—Diarrhoea—Gemcitabine—urinary bladder cancer	8.61e-05	0.00114	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—urinary bladder cancer	8.56e-05	0.00113	CcSEcCtD
Simvastatin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	8.56e-05	0.00113	CcSEcCtD
Simvastatin—Urticaria—Etoposide—urinary bladder cancer	8.53e-05	0.00113	CcSEcCtD
Simvastatin—Jaundice—Doxorubicin—urinary bladder cancer	8.52e-05	0.00113	CcSEcCtD
Simvastatin—Body temperature increased—Etoposide—urinary bladder cancer	8.49e-05	0.00112	CcSEcCtD
Simvastatin—Abdominal pain—Etoposide—urinary bladder cancer	8.49e-05	0.00112	CcSEcCtD
Simvastatin—Hepatitis—Epirubicin—urinary bladder cancer	8.48e-05	0.00112	CcSEcCtD
Simvastatin—Diarrhoea—Fluorouracil—urinary bladder cancer	8.46e-05	0.00112	CcSEcCtD
Simvastatin—Asthenia—Cisplatin—urinary bladder cancer	8.41e-05	0.00111	CcSEcCtD
Simvastatin—Sinusitis—Doxorubicin—urinary bladder cancer	8.2e-05	0.00108	CcSEcCtD
Simvastatin—Dizziness—Fluorouracil—urinary bladder cancer	8.18e-05	0.00108	CcSEcCtD
Simvastatin—Chills—Methotrexate—urinary bladder cancer	8.13e-05	0.00107	CcSEcCtD
Simvastatin—Diarrhoea—Cisplatin—urinary bladder cancer	8.02e-05	0.00106	CcSEcCtD
Simvastatin—Erythema multiforme—Epirubicin—urinary bladder cancer	8.01e-05	0.00106	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—urinary bladder cancer	8e-05	0.00106	CcSEcCtD
Simvastatin—Vomiting—Gemcitabine—urinary bladder cancer	8e-05	0.00106	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—urinary bladder cancer	7.93e-05	0.00105	CcSEcCtD
Simvastatin—Rash—Gemcitabine—urinary bladder cancer	7.93e-05	0.00105	CcSEcCtD
Simvastatin—Dermatitis—Gemcitabine—urinary bladder cancer	7.92e-05	0.00105	CcSEcCtD
Simvastatin—Hypersensitivity—Etoposide—urinary bladder cancer	7.91e-05	0.00105	CcSEcCtD
Simvastatin—Erythema—Methotrexate—urinary bladder cancer	7.88e-05	0.00104	CcSEcCtD
Simvastatin—Headache—Gemcitabine—urinary bladder cancer	7.88e-05	0.00104	CcSEcCtD
Simvastatin—Flushing—Epirubicin—urinary bladder cancer	7.87e-05	0.00104	CcSEcCtD
Simvastatin—Vomiting—Fluorouracil—urinary bladder cancer	7.86e-05	0.00104	CcSEcCtD
Simvastatin—Hepatitis—Doxorubicin—urinary bladder cancer	7.84e-05	0.00104	CcSEcCtD
Simvastatin—Rash—Fluorouracil—urinary bladder cancer	7.8e-05	0.00103	CcSEcCtD
Simvastatin—Dermatitis—Fluorouracil—urinary bladder cancer	7.79e-05	0.00103	CcSEcCtD
Simvastatin—Headache—Fluorouracil—urinary bladder cancer	7.75e-05	0.00102	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—urinary bladder cancer	7.72e-05	0.00102	CcSEcCtD
Simvastatin—Asthenia—Etoposide—urinary bladder cancer	7.71e-05	0.00102	CcSEcCtD
Simvastatin—Chills—Epirubicin—urinary bladder cancer	7.61e-05	0.00101	CcSEcCtD
Simvastatin—Pruritus—Etoposide—urinary bladder cancer	7.6e-05	0.00101	CcSEcCtD
Simvastatin—Alopecia—Epirubicin—urinary bladder cancer	7.49e-05	0.000991	CcSEcCtD
Simvastatin—Nausea—Gemcitabine—urinary bladder cancer	7.47e-05	0.000988	CcSEcCtD
Simvastatin—Vomiting—Cisplatin—urinary bladder cancer	7.46e-05	0.000986	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—urinary bladder cancer	7.43e-05	0.000983	CcSEcCtD
Simvastatin—Mental disorder—Epirubicin—urinary bladder cancer	7.43e-05	0.000982	CcSEcCtD
Simvastatin—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.42e-05	0.000981	CcSEcCtD
Simvastatin—Rash—Cisplatin—urinary bladder cancer	7.39e-05	0.000978	CcSEcCtD
Simvastatin—Dermatitis—Cisplatin—urinary bladder cancer	7.39e-05	0.000977	CcSEcCtD
Simvastatin—Erythema—Epirubicin—urinary bladder cancer	7.38e-05	0.000976	CcSEcCtD
Simvastatin—Diarrhoea—Etoposide—urinary bladder cancer	7.35e-05	0.000972	CcSEcCtD
Simvastatin—Nausea—Fluorouracil—urinary bladder cancer	7.35e-05	0.000972	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—urinary bladder cancer	7.32e-05	0.000967	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—urinary bladder cancer	7.29e-05	0.000964	CcSEcCtD
Simvastatin—Flushing—Doxorubicin—urinary bladder cancer	7.28e-05	0.000963	CcSEcCtD
Simvastatin—Flatulence—Epirubicin—urinary bladder cancer	7.27e-05	0.000962	CcSEcCtD
Simvastatin—Dysgeusia—Epirubicin—urinary bladder cancer	7.23e-05	0.000956	CcSEcCtD
Simvastatin—Malaise—Methotrexate—urinary bladder cancer	7.11e-05	0.00094	CcSEcCtD
Simvastatin—Dizziness—Etoposide—urinary bladder cancer	7.1e-05	0.00094	CcSEcCtD
Simvastatin—Muscle spasms—Epirubicin—urinary bladder cancer	7.09e-05	0.000938	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—urinary bladder cancer	7.08e-05	0.000937	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—urinary bladder cancer	7.06e-05	0.000933	CcSEcCtD
Simvastatin—Chills—Doxorubicin—urinary bladder cancer	7.04e-05	0.000931	CcSEcCtD
Simvastatin—Nausea—Cisplatin—urinary bladder cancer	6.97e-05	0.000921	CcSEcCtD
Simvastatin—Vision blurred—Epirubicin—urinary bladder cancer	6.95e-05	0.00092	CcSEcCtD
Simvastatin—Alopecia—Doxorubicin—urinary bladder cancer	6.93e-05	0.000917	CcSEcCtD
Simvastatin—Mental disorder—Doxorubicin—urinary bladder cancer	6.87e-05	0.000909	CcSEcCtD
Simvastatin—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.85e-05	0.000905	CcSEcCtD
Simvastatin—Vomiting—Etoposide—urinary bladder cancer	6.83e-05	0.000903	CcSEcCtD
Simvastatin—Erythema—Doxorubicin—urinary bladder cancer	6.83e-05	0.000903	CcSEcCtD
Simvastatin—Anaemia—Epirubicin—urinary bladder cancer	6.82e-05	0.000902	CcSEcCtD
Simvastatin—Rash—Etoposide—urinary bladder cancer	6.77e-05	0.000896	CcSEcCtD
Simvastatin—Dermatitis—Etoposide—urinary bladder cancer	6.77e-05	0.000895	CcSEcCtD
Simvastatin—Headache—Etoposide—urinary bladder cancer	6.73e-05	0.00089	CcSEcCtD
Simvastatin—Flatulence—Doxorubicin—urinary bladder cancer	6.73e-05	0.00089	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—urinary bladder cancer	6.71e-05	0.000888	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—urinary bladder cancer	6.71e-05	0.000888	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—urinary bladder cancer	6.71e-05	0.000888	CcSEcCtD
Simvastatin—Dysgeusia—Doxorubicin—urinary bladder cancer	6.69e-05	0.000884	CcSEcCtD
Simvastatin—Malaise—Epirubicin—urinary bladder cancer	6.65e-05	0.00088	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—urinary bladder cancer	6.63e-05	0.000877	CcSEcCtD
Simvastatin—Vertigo—Epirubicin—urinary bladder cancer	6.63e-05	0.000877	CcSEcCtD
Simvastatin—Leukopenia—Epirubicin—urinary bladder cancer	6.6e-05	0.000873	CcSEcCtD
Simvastatin—Muscle spasms—Doxorubicin—urinary bladder cancer	6.56e-05	0.000868	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—urinary bladder cancer	6.49e-05	0.000858	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—urinary bladder cancer	6.43e-05	0.000851	CcSEcCtD
Simvastatin—Vision blurred—Doxorubicin—urinary bladder cancer	6.43e-05	0.000851	CcSEcCtD
Simvastatin—Infection—Methotrexate—urinary bladder cancer	6.39e-05	0.000845	CcSEcCtD
Simvastatin—Nausea—Etoposide—urinary bladder cancer	6.38e-05	0.000844	CcSEcCtD
Simvastatin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.33e-05	0.000838	CcSEcCtD
Simvastatin—Anaemia—Doxorubicin—urinary bladder cancer	6.31e-05	0.000835	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—urinary bladder cancer	6.3e-05	0.000833	CcSEcCtD
Simvastatin—Arthralgia—Epirubicin—urinary bladder cancer	6.28e-05	0.000831	CcSEcCtD
Simvastatin—Chest pain—Epirubicin—urinary bladder cancer	6.28e-05	0.000831	CcSEcCtD
Simvastatin—Myalgia—Epirubicin—urinary bladder cancer	6.28e-05	0.000831	CcSEcCtD
Simvastatin—Anxiety—Epirubicin—urinary bladder cancer	6.26e-05	0.000828	CcSEcCtD
Simvastatin—Discomfort—Epirubicin—urinary bladder cancer	6.21e-05	0.000821	CcSEcCtD
Simvastatin—Malaise—Doxorubicin—urinary bladder cancer	6.16e-05	0.000814	CcSEcCtD
Simvastatin—Vertigo—Doxorubicin—urinary bladder cancer	6.13e-05	0.000811	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—urinary bladder cancer	6.13e-05	0.000811	CcSEcCtD
Simvastatin—Leukopenia—Doxorubicin—urinary bladder cancer	6.11e-05	0.000808	CcSEcCtD
Simvastatin—Confusional state—Epirubicin—urinary bladder cancer	6.07e-05	0.000803	CcSEcCtD
Simvastatin—Anaphylactic shock—Epirubicin—urinary bladder cancer	6.02e-05	0.000796	CcSEcCtD
Simvastatin—Oedema—Epirubicin—urinary bladder cancer	6.02e-05	0.000796	CcSEcCtD
Simvastatin—Infection—Epirubicin—urinary bladder cancer	5.98e-05	0.000791	CcSEcCtD
Simvastatin—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.9e-05	0.00078	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.86e-05	0.000775	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—urinary bladder cancer	5.82e-05	0.00077	CcSEcCtD
Simvastatin—Arthralgia—Doxorubicin—urinary bladder cancer	5.81e-05	0.000769	CcSEcCtD
Simvastatin—Chest pain—Doxorubicin—urinary bladder cancer	5.81e-05	0.000769	CcSEcCtD
Simvastatin—Myalgia—Doxorubicin—urinary bladder cancer	5.81e-05	0.000769	CcSEcCtD
Simvastatin—Anxiety—Doxorubicin—urinary bladder cancer	5.79e-05	0.000766	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—urinary bladder cancer	5.78e-05	0.000764	CcSEcCtD
Simvastatin—Discomfort—Doxorubicin—urinary bladder cancer	5.74e-05	0.000759	CcSEcCtD
Simvastatin—Anorexia—Epirubicin—urinary bladder cancer	5.74e-05	0.000759	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—urinary bladder cancer	5.74e-05	0.000759	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—urinary bladder cancer	5.66e-05	0.000749	CcSEcCtD
Simvastatin—Confusional state—Doxorubicin—urinary bladder cancer	5.62e-05	0.000743	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—urinary bladder cancer	5.59e-05	0.00074	CcSEcCtD
Simvastatin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	5.57e-05	0.000737	CcSEcCtD
Simvastatin—Oedema—Doxorubicin—urinary bladder cancer	5.57e-05	0.000737	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.56e-05	0.000735	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—urinary bladder cancer	5.55e-05	0.000734	CcSEcCtD
Simvastatin—Infection—Doxorubicin—urinary bladder cancer	5.54e-05	0.000732	CcSEcCtD
Simvastatin—Pain—Methotrexate—urinary bladder cancer	5.5e-05	0.000728	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.49e-05	0.000726	CcSEcCtD
Simvastatin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.46e-05	0.000721	CcSEcCtD
Simvastatin—Insomnia—Epirubicin—urinary bladder cancer	5.45e-05	0.00072	CcSEcCtD
Simvastatin—Paraesthesia—Epirubicin—urinary bladder cancer	5.41e-05	0.000715	CcSEcCtD
Simvastatin—Dyspnoea—Epirubicin—urinary bladder cancer	5.37e-05	0.00071	CcSEcCtD
Simvastatin—Anorexia—Doxorubicin—urinary bladder cancer	5.31e-05	0.000702	CcSEcCtD
Simvastatin—Feeling abnormal—Methotrexate—urinary bladder cancer	5.3e-05	0.000701	CcSEcCtD
Simvastatin—Dyspepsia—Epirubicin—urinary bladder cancer	5.3e-05	0.000701	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5.26e-05	0.000696	CcSEcCtD
Simvastatin—Decreased appetite—Epirubicin—urinary bladder cancer	5.23e-05	0.000692	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	5.2e-05	0.000688	CcSEcCtD
Simvastatin—Fatigue—Epirubicin—urinary bladder cancer	5.19e-05	0.000687	CcSEcCtD
Simvastatin—Pain—Epirubicin—urinary bladder cancer	5.15e-05	0.000681	CcSEcCtD
Simvastatin—Constipation—Epirubicin—urinary bladder cancer	5.15e-05	0.000681	CcSEcCtD
Simvastatin—Urticaria—Methotrexate—urinary bladder cancer	5.11e-05	0.000676	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—urinary bladder cancer	5.09e-05	0.000673	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—urinary bladder cancer	5.09e-05	0.000673	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	5.08e-05	0.000671	CcSEcCtD
Simvastatin—Insomnia—Doxorubicin—urinary bladder cancer	5.04e-05	0.000666	CcSEcCtD
Simvastatin—Paraesthesia—Doxorubicin—urinary bladder cancer	5e-05	0.000662	CcSEcCtD
Simvastatin—Dyspnoea—Doxorubicin—urinary bladder cancer	4.97e-05	0.000657	CcSEcCtD
Simvastatin—Feeling abnormal—Epirubicin—urinary bladder cancer	4.96e-05	0.000656	CcSEcCtD
Simvastatin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.92e-05	0.000651	CcSEcCtD
Simvastatin—Dyspepsia—Doxorubicin—urinary bladder cancer	4.9e-05	0.000649	CcSEcCtD
Simvastatin—Decreased appetite—Doxorubicin—urinary bladder cancer	4.84e-05	0.000641	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.81e-05	0.000636	CcSEcCtD
Simvastatin—Fatigue—Doxorubicin—urinary bladder cancer	4.8e-05	0.000635	CcSEcCtD
Simvastatin—Urticaria—Epirubicin—urinary bladder cancer	4.78e-05	0.000633	CcSEcCtD
Simvastatin—Constipation—Doxorubicin—urinary bladder cancer	4.76e-05	0.00063	CcSEcCtD
Simvastatin—Pain—Doxorubicin—urinary bladder cancer	4.76e-05	0.00063	CcSEcCtD
Simvastatin—Abdominal pain—Epirubicin—urinary bladder cancer	4.76e-05	0.00063	CcSEcCtD
Simvastatin—Body temperature increased—Epirubicin—urinary bladder cancer	4.76e-05	0.00063	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—urinary bladder cancer	4.74e-05	0.000627	CcSEcCtD
Simvastatin—Asthenia—Methotrexate—urinary bladder cancer	4.62e-05	0.000611	CcSEcCtD
Simvastatin—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.59e-05	0.000607	CcSEcCtD
Simvastatin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.56e-05	0.000603	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—urinary bladder cancer	4.55e-05	0.000602	CcSEcCtD
Simvastatin—Hypersensitivity—Epirubicin—urinary bladder cancer	4.44e-05	0.000587	CcSEcCtD
Simvastatin—Urticaria—Doxorubicin—urinary bladder cancer	4.43e-05	0.000585	CcSEcCtD
Simvastatin—Abdominal pain—Doxorubicin—urinary bladder cancer	4.4e-05	0.000583	CcSEcCtD
Simvastatin—Body temperature increased—Doxorubicin—urinary bladder cancer	4.4e-05	0.000583	CcSEcCtD
Simvastatin—Diarrhoea—Methotrexate—urinary bladder cancer	4.4e-05	0.000582	CcSEcCtD
Simvastatin—Asthenia—Epirubicin—urinary bladder cancer	4.32e-05	0.000571	CcSEcCtD
Simvastatin—Pruritus—Epirubicin—urinary bladder cancer	4.26e-05	0.000563	CcSEcCtD
Simvastatin—Dizziness—Methotrexate—urinary bladder cancer	4.26e-05	0.000563	CcSEcCtD
Simvastatin—Diarrhoea—Epirubicin—urinary bladder cancer	4.12e-05	0.000545	CcSEcCtD
Simvastatin—Hypersensitivity—Doxorubicin—urinary bladder cancer	4.11e-05	0.000543	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—urinary bladder cancer	4.09e-05	0.000541	CcSEcCtD
Simvastatin—Rash—Methotrexate—urinary bladder cancer	4.06e-05	0.000537	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—urinary bladder cancer	4.05e-05	0.000536	CcSEcCtD
Simvastatin—Headache—Methotrexate—urinary bladder cancer	4.03e-05	0.000533	CcSEcCtD
Simvastatin—Asthenia—Doxorubicin—urinary bladder cancer	4e-05	0.000529	CcSEcCtD
Simvastatin—Dizziness—Epirubicin—urinary bladder cancer	3.98e-05	0.000527	CcSEcCtD
Simvastatin—Pruritus—Doxorubicin—urinary bladder cancer	3.94e-05	0.000521	CcSEcCtD
Simvastatin—Vomiting—Epirubicin—urinary bladder cancer	3.83e-05	0.000506	CcSEcCtD
Simvastatin—Nausea—Methotrexate—urinary bladder cancer	3.82e-05	0.000505	CcSEcCtD
Simvastatin—Diarrhoea—Doxorubicin—urinary bladder cancer	3.81e-05	0.000504	CcSEcCtD
Simvastatin—Rash—Epirubicin—urinary bladder cancer	3.8e-05	0.000502	CcSEcCtD
Simvastatin—Dermatitis—Epirubicin—urinary bladder cancer	3.79e-05	0.000502	CcSEcCtD
Simvastatin—Headache—Epirubicin—urinary bladder cancer	3.77e-05	0.000499	CcSEcCtD
Simvastatin—Dizziness—Doxorubicin—urinary bladder cancer	3.68e-05	0.000487	CcSEcCtD
Simvastatin—Nausea—Epirubicin—urinary bladder cancer	3.58e-05	0.000473	CcSEcCtD
Simvastatin—Vomiting—Doxorubicin—urinary bladder cancer	3.54e-05	0.000469	CcSEcCtD
Simvastatin—Rash—Doxorubicin—urinary bladder cancer	3.51e-05	0.000465	CcSEcCtD
Simvastatin—Dermatitis—Doxorubicin—urinary bladder cancer	3.51e-05	0.000464	CcSEcCtD
Simvastatin—Headache—Doxorubicin—urinary bladder cancer	3.49e-05	0.000462	CcSEcCtD
Simvastatin—Nausea—Doxorubicin—urinary bladder cancer	3.31e-05	0.000438	CcSEcCtD
Simvastatin—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	9.52e-06	0.000116	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.47e-06	0.000116	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	9.45e-06	0.000115	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	9.44e-06	0.000115	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.25e-06	0.000113	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.21e-06	0.000112	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	9.18e-06	0.000112	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	9e-06	0.00011	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	8.96e-06	0.000109	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	8.89e-06	0.000108	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	8.88e-06	0.000108	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	8.88e-06	0.000108	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	8.85e-06	0.000108	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	8.75e-06	0.000107	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	8.75e-06	0.000107	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NAT2—urinary bladder cancer	8.71e-06	0.000106	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	8.68e-06	0.000106	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.62e-06	0.000105	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	8.59e-06	0.000105	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	8.53e-06	0.000104	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	8.53e-06	0.000104	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PPARG—urinary bladder cancer	8.47e-06	0.000103	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TYMP—urinary bladder cancer	8.39e-06	0.000102	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	8.38e-06	0.000102	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—TYMS—urinary bladder cancer	8.26e-06	0.000101	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.26e-06	0.000101	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.25e-06	0.000101	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	8.23e-06	0.0001	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	8.23e-06	0.0001	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	8.22e-06	0.0001	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	8.22e-06	0.0001	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—urinary bladder cancer	8.17e-06	9.97e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	8.17e-06	9.96e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	8.17e-06	9.96e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	8.14e-06	9.94e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	8.14e-06	9.93e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.05e-06	9.82e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	8.04e-06	9.81e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	8.04e-06	9.81e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	7.97e-06	9.73e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TYMP—urinary bladder cancer	7.9e-06	9.64e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.88e-06	9.61e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.86e-06	9.59e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TYMP—urinary bladder cancer	7.84e-06	9.56e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—GPX1—urinary bladder cancer	7.82e-06	9.54e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	7.8e-06	9.52e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	7.79e-06	9.51e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	7.77e-06	9.48e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	7.73e-06	9.44e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	7.68e-06	9.37e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	7.67e-06	9.36e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	7.6e-06	9.28e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NAT2—urinary bladder cancer	7.58e-06	9.26e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	7.57e-06	9.24e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.53e-06	9.18e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—RRM2—urinary bladder cancer	7.52e-06	9.17e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	7.48e-06	9.13e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	7.48e-06	9.13e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	7.47e-06	9.12e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	7.22e-06	8.81e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PPARG—urinary bladder cancer	7.2e-06	8.79e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	7.17e-06	8.74e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NAT2—urinary bladder cancer	7.15e-06	8.72e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTEN—urinary bladder cancer	7.13e-06	8.7e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.09e-06	8.65e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	7.04e-06	8.59e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.02e-06	8.57e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	6.96e-06	8.49e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ENO2—urinary bladder cancer	6.96e-06	8.49e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	6.95e-06	8.48e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.92e-06	8.44e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	6.92e-06	8.44e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	6.87e-06	8.38e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	6.87e-06	8.38e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—EP300—urinary bladder cancer	6.8e-06	8.3e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	6.76e-06	8.25e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	6.75e-06	8.24e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	6.71e-06	8.19e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	6.66e-06	8.13e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.65e-06	8.11e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	6.63e-06	8.09e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	6.63e-06	8.09e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	6.61e-06	8.07e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	6.58e-06	8.03e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—RRM2—urinary bladder cancer	6.55e-06	7.99e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	6.48e-06	7.9e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	6.46e-06	7.89e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	6.46e-06	7.88e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	6.27e-06	7.65e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	6.21e-06	7.58e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	6.21e-06	7.58e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.18e-06	7.54e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.17e-06	7.53e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.12e-06	7.46e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	6.07e-06	7.41e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	6.06e-06	7.4e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ENO2—urinary bladder cancer	6.06e-06	7.4e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	6.03e-06	7.35e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	6.02e-06	7.35e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.93e-06	7.24e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	5.88e-06	7.18e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—urinary bladder cancer	5.85e-06	7.14e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTEN—urinary bladder cancer	5.81e-06	7.09e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.71e-06	6.97e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.71e-06	6.97e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	5.67e-06	6.91e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	5.66e-06	6.91e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ENO2—urinary bladder cancer	5.66e-06	6.91e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.63e-06	6.87e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	5.62e-06	6.86e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NQO1—urinary bladder cancer	5.61e-06	6.85e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.54e-06	6.76e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—EP300—urinary bladder cancer	5.54e-06	6.76e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	5.53e-06	6.74e-05	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.51e-06	6.72e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.49e-06	6.7e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.44e-06	6.64e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.41e-06	6.6e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	5.4e-06	6.59e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	5.36e-06	6.54e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.17e-06	6.31e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	5.15e-06	6.29e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	5.14e-06	6.27e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	5.08e-06	6.2e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	5.08e-06	6.2e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	5.02e-06	6.13e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.01e-06	6.11e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.96e-06	6.06e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.96e-06	6.06e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTEN—urinary bladder cancer	4.94e-06	6.03e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	4.93e-06	6.02e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	4.92e-06	6.01e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NQO1—urinary bladder cancer	4.89e-06	5.96e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	4.86e-06	5.94e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.86e-06	5.93e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	4.78e-06	5.83e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	4.75e-06	5.8e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.75e-06	5.79e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	4.73e-06	5.77e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—EP300—urinary bladder cancer	4.71e-06	5.75e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	4.68e-06	5.71e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	4.67e-06	5.7e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	4.67e-06	5.7e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.61e-06	5.62e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	4.6e-06	5.62e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.57e-06	5.57e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.53e-06	5.52e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	4.49e-06	5.48e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.43e-06	5.41e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	4.39e-06	5.35e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.35e-06	5.31e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	4.3e-06	5.25e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.3e-06	5.25e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.3e-06	5.25e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.24e-06	5.17e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	4.22e-06	5.15e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.18e-06	5.1e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GPX1—urinary bladder cancer	4.12e-06	5.02e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—EP300—urinary bladder cancer	4.1e-06	5.01e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.08e-06	4.97e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.04e-06	4.93e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.04e-06	4.93e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.03e-06	4.92e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTEN—urinary bladder cancer	4.01e-06	4.9e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.88e-06	4.74e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	3.87e-06	4.72e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.86e-06	4.71e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.84e-06	4.69e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.84e-06	4.68e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.84e-06	4.68e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—EP300—urinary bladder cancer	3.83e-06	4.67e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.81e-06	4.65e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	3.8e-06	4.64e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TYMS—urinary bladder cancer	3.79e-06	4.62e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	3.75e-06	4.57e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	3.75e-06	4.57e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.74e-06	4.56e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.74e-06	4.56e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.68e-06	4.5e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	3.68e-06	4.49e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	3.68e-06	4.49e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	3.64e-06	4.44e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.62e-06	4.42e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.61e-06	4.4e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.59e-06	4.38e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.57e-06	4.36e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	3.56e-06	4.34e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.54e-06	4.32e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.53e-06	4.31e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.53e-06	4.31e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.52e-06	4.3e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—EP300—urinary bladder cancer	3.51e-06	4.28e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	3.5e-06	4.27e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	3.42e-06	4.17e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.39e-06	4.14e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.38e-06	4.13e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	3.38e-06	4.12e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.35e-06	4.09e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.32e-06	4.05e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.31e-06	4.04e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.29e-06	4.02e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—EP300—urinary bladder cancer	3.22e-06	3.93e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.12e-06	3.81e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.09e-06	3.77e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.08e-06	3.76e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.01e-06	3.67e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.96e-06	3.61e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	2.86e-06	3.49e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.8e-06	3.42e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.75e-06	3.36e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.68e-06	3.28e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.64e-06	3.22e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.58e-06	3.15e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.53e-06	3.09e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.51e-06	3.06e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.51e-06	3.06e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	2.5e-06	3.05e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.44e-06	2.98e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.43e-06	2.97e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.42e-06	2.96e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.41e-06	2.94e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—EP300—urinary bladder cancer	2.38e-06	2.91e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.33e-06	2.85e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—EP300—urinary bladder cancer	2.33e-06	2.84e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.31e-06	2.82e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.31e-06	2.82e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.21e-06	2.7e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.17e-06	2.65e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.16e-06	2.64e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.11e-06	2.58e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.11e-06	2.58e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.04e-06	2.49e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.02e-06	2.46e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.99e-06	2.43e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.97e-06	2.41e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.89e-06	2.3e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.84e-06	2.25e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.8e-06	2.2e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—EP300—urinary bladder cancer	1.76e-06	2.14e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.74e-06	2.12e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.72e-06	2.1e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.66e-06	2.02e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.65e-06	2.02e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.64e-06	2e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.59e-06	1.94e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.3e-06	1.59e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.13e-06	1.38e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.08e-06	1.32e-05	CbGpPWpGaD
